世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

インターベンショナルカーディオロジーデバイスの市場規模、シェア、動向分析レポート:製品別(冠動脈ステント、PTCAバルーンカテーテル、付属デバイス)、地域別、セグメント別予測、2023年~2030年


Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Accessory Devices), By Region, And Segment Forecasts, 2023 - 2030

インターベンショナル・カーディオロジー・デバイス市場の成長と動向 Grand View Research Inc.の最新レポートによると、世界のインターベンショナルカーディオロジー機器市場規模は2030年までに223億5000万米... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年10月4日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
150 英語

本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。


 

サマリー

インターベンショナル・カーディオロジー・デバイス市場の成長と動向

Grand View Research Inc.の最新レポートによると、世界のインターベンショナルカーディオロジー機器市場規模は2030年までに223億5000万米ドルに達する見込みです。同市場は、2023年から2030年にかけてCAGR 7.2%で拡大する見込みです。冠動脈インターベンション手技に対する有利な償還政策、世界的な心血管疾患(CVDs)および糖尿病の有病率の上昇、同市場における新製品ラインの発売などにより、インターベンショナル心臓病学機器に対する需要は増加傾向にあります。心血管疾患は、世界における死亡率および罹患率の主な原因の1つとなっている。冠動脈疾患と先天性心疾患は、世界中で流行している主要な心血管疾患である。

さらに、喫煙、座りっぱなしの生活、不適切な食事などの不健康なライフスタイルの採用が糖尿病の原因となっている。心臓カテーテル治療、血管形成術、経皮的冠動脈インターベンション(PCI)は、心血管疾患の治療に用いられる主要な手技のひとつである。糖尿病は心血管疾患を引き起こす主な原因の1つであるため、糖尿病患者の増加は予測期間中にインターベンショナル・カーディオロジー機器の需要を急増させると予想される。市場は今後数年間で拡大すると予想されるが、特に保険適用が不十分な発展途上国では、医療機器の高価格が原因で成長が鈍化する可能性がある。

インターベンショナル心臓病学機器市場レポートハイライト

- 冠動脈ステント分野が2022年の売上高シェア64.6%で市場を独占。冠動脈ステント部門ではDESが売上の大半を占める。

- 分岐型ステントの開発や生分解性材料の使用など、冠動脈ステントの技術的進歩は、CVD治療の効率的で改善された治療成績につながっている。各社は製品開発やパートナーシップ、戦略的提携に積極的に取り組んでいる。前述の要因は、予測期間中の業界の成長を促進すると予想される。

- アジア太平洋地域は予測期間中最も速いCAGR 7.9%で成長すると予想される。この成長は、冠動脈疾患(CAD)の罹患率の増加や、この疾患のスクリーニング対策の改善など、いくつかの要因によるものである。

- 市場は複数の企業が存在するため断片化している。このため、今後数年間は競争が激化すると予想される。市場参入企業は、市場での存在感を高めるため、提携、販売・マーケティング活動、M&A、サービス拡大、統合提供、製品発売など、さまざまな戦略的イニシアティブを採用している。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Interventional Cardiology Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Interventional Cardiology Devices Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Interventional Cardiology Devices Market: Product Estimates & Trend Analysis
4.1. Interventional Cardiology Devices Market: Key Takeaways
4.2. Interventional Cardiology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Coronary Stents
4.3.1. Coronary stents market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. DES
4.3.2.1. DES market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. BMS
4.3.3.1. BMS market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. BRS
4.3.4.1. BRS market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. PTCA Balloon Catheters
4.4.1. PTCA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Normal
4.4.2.1. Normal market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Specialty
4.4.3.1. Specialty market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. DCB
4.4.4.1. DCB market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Accessory Devices
4.5.1. Accessory devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. PTCA guidewires
4.5.2.1. PTCA guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Diagnostic catheters
4.5.3.1. Diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. PTCA guiding catheters
4.5.4.1. PTCA guiding catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.5. Introducer sheaths
4.5.5.1. Introducer sheaths market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Intravascular imaging catheters and pressure guidewires
4.6.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Interventional Cardiology Devices Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Interventional Cardiology Devices Market by Region: Key Takeaways
5.3. North America
5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. UK
5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. Germany
5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. France
5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Italy
5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Spain
5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.9. Denmark
5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. Japan
5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. China
5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. India
5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Australia
5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. Thailand
5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.7. South Korea
5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Brazil
5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Mexico
5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.4. Argentina
5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. South Africa
5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. UAE
5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.5. Kuwait
5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Abbott Laboratories
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Medtronic
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Boston Scientific
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Spectranetics
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Cardinal Health
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Philips Healthcare
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Terumo
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Alvimedica
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Teleflex Medical
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. B. Braun
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Biosensors International
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. Meril Life Sciences
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
6.2.13. BIOTRONIK
6.2.13.1. Company overview
6.2.13.2. Financial performance
6.2.13.3. Product benchmarking
6.2.13.4. Strategic initiatives
6.2.14. ACIST Medical Systems
6.2.14.1. Company overview
6.2.14.2. Financial performance
6.2.14.3. Product benchmarking
6.2.14.4. Strategic initiatives
6.2.15. ASAHI INTECC
6.2.15.1. Company overview
6.2.15.2. Financial performance
6.2.15.3. Product benchmarking
6.2.15.4. Strategic initiatives
6.2.16. CID Vascular
6.2.16.1. Company overview
6.2.16.2. Financial performance
6.2.16.3. Product benchmarking
6.2.16.4. Strategic initiatives
6.2.17. Cook Medical
6.2.17.1. Company overview
6.2.17.2. Financial performance
6.2.17.3. Product benchmarking
6.2.17.4. Strategic initiatives
6.2.18. Medinol
6.2.18.1. Company overview
6.2.18.2. Financial performance
6.2.18.3. Product benchmarking
6.2.18.4. Strategic initiatives
6.2.19. Merit Medical Systems
6.2.19.1. Company overview
6.2.19.2. Financial performance
6.2.19.3. Product benchmarking
6.2.19.4. Strategic initiatives
6.2.20. NuMED
6.2.20.1. Company overview
6.2.20.2. Financial performance
6.2.20.3. Product benchmarking
6.2.20.4. Strategic initiatives
6.2.21. OpSens
6.2.21.1. Company overview
6.2.21.2. Financial performance
6.2.21.3. Product benchmarking
6.2.21.4. Strategic initiatives
6.2.22. Vascular Solutions
6.2.22.1. Company overview
6.2.22.2. Financial performance
6.2.22.3. Product benchmarking
6.2.22.4. Strategic initiatives
6.2.23. Zeon Medical
6.2.23.1. Company overview
6.2.23.2. Financial performance
6.2.23.3. Product benchmarking
6.2.23.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

Interventional Cardiology Devices Market Growth & Trends

The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030, according to a new report by Grand View Research Inc. The market is expected to expand at a CAGR of 7.2% from 2023 to 2030 Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe.

Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.

Interventional Cardiology Devices Market Report Highlights

• The coronary stents segment dominated the market with the largest revenue share of 64.6% in 2022. DES makes up the majority of sales in the coronary stent category.

• Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period

• Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.

• The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Interventional Cardiology Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Interventional Cardiology Devices Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Interventional Cardiology Devices Market: Product Estimates & Trend Analysis
4.1. Interventional Cardiology Devices Market: Key Takeaways
4.2. Interventional Cardiology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Coronary Stents
4.3.1. Coronary stents market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. DES
4.3.2.1. DES market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. BMS
4.3.3.1. BMS market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. BRS
4.3.4.1. BRS market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. PTCA Balloon Catheters
4.4.1. PTCA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Normal
4.4.2.1. Normal market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Specialty
4.4.3.1. Specialty market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. DCB
4.4.4.1. DCB market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Accessory Devices
4.5.1. Accessory devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. PTCA guidewires
4.5.2.1. PTCA guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Diagnostic catheters
4.5.3.1. Diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. PTCA guiding catheters
4.5.4.1. PTCA guiding catheters market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.5. Introducer sheaths
4.5.5.1. Introducer sheaths market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Intravascular imaging catheters and pressure guidewires
4.6.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Interventional Cardiology Devices Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Interventional Cardiology Devices Market by Region: Key Takeaways
5.3. North America
5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. UK
5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. Germany
5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. France
5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Italy
5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Spain
5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.9. Denmark
5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. Japan
5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. China
5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. India
5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Australia
5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. Thailand
5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.7. South Korea
5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Brazil
5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Mexico
5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.4. Argentina
5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. South Africa
5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. UAE
5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.5. Kuwait
5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Abbott Laboratories
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Medtronic
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Boston Scientific
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. Spectranetics
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Cardinal Health
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Philips Healthcare
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Terumo
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Alvimedica
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Teleflex Medical
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. B. Braun
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
6.2.11. Biosensors International
6.2.11.1. Company overview
6.2.11.2. Financial performance
6.2.11.3. Product benchmarking
6.2.11.4. Strategic initiatives
6.2.12. Meril Life Sciences
6.2.12.1. Company overview
6.2.12.2. Financial performance
6.2.12.3. Product benchmarking
6.2.12.4. Strategic initiatives
6.2.13. BIOTRONIK
6.2.13.1. Company overview
6.2.13.2. Financial performance
6.2.13.3. Product benchmarking
6.2.13.4. Strategic initiatives
6.2.14. ACIST Medical Systems
6.2.14.1. Company overview
6.2.14.2. Financial performance
6.2.14.3. Product benchmarking
6.2.14.4. Strategic initiatives
6.2.15. ASAHI INTECC
6.2.15.1. Company overview
6.2.15.2. Financial performance
6.2.15.3. Product benchmarking
6.2.15.4. Strategic initiatives
6.2.16. CID Vascular
6.2.16.1. Company overview
6.2.16.2. Financial performance
6.2.16.3. Product benchmarking
6.2.16.4. Strategic initiatives
6.2.17. Cook Medical
6.2.17.1. Company overview
6.2.17.2. Financial performance
6.2.17.3. Product benchmarking
6.2.17.4. Strategic initiatives
6.2.18. Medinol
6.2.18.1. Company overview
6.2.18.2. Financial performance
6.2.18.3. Product benchmarking
6.2.18.4. Strategic initiatives
6.2.19. Merit Medical Systems
6.2.19.1. Company overview
6.2.19.2. Financial performance
6.2.19.3. Product benchmarking
6.2.19.4. Strategic initiatives
6.2.20. NuMED
6.2.20.1. Company overview
6.2.20.2. Financial performance
6.2.20.3. Product benchmarking
6.2.20.4. Strategic initiatives
6.2.21. OpSens
6.2.21.1. Company overview
6.2.21.2. Financial performance
6.2.21.3. Product benchmarking
6.2.21.4. Strategic initiatives
6.2.22. Vascular Solutions
6.2.22.1. Company overview
6.2.22.2. Financial performance
6.2.22.3. Product benchmarking
6.2.22.4. Strategic initiatives
6.2.23. Zeon Medical
6.2.23.1. Company overview
6.2.23.2. Financial performance
6.2.23.3. Product benchmarking
6.2.23.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD(cardiology)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る